Table 2.

The association between gene polymorphism of XRCC1 (rs25487), TP53(rs1042522) and cervical cancer

Variable	Groups	Co-dominate model				Recessive model
			P-value	OR	95%CI	P-value	OR	95%CI
rs25487	Cases vs NC	G/A	0.00*	2.00	1.14–3.50	0.02*	2.54	1.15–5.59
		A/A		3.43	1.50–7.85
	Cases vs OC	G/A	0.03*	1.61	0.91–2.87	0.03*	2.40	1.06–5.46
		A/A		3.00	1.26–7.10
	NC vs OC	G/A	0.76	0.81	0.45–1.43	0.91	0.95	0.37–2.43
		A/A		0.87	0.33–2.30
rs1042522	Cases vs NC	G/C	0.54	0.73	0.41–1.29	0.82	0.92	0.47–1.82
		C/C		0.78	0.37–1.64
	Cases vs OC	G/C	0.41	0.88	0.48–1.59	0.21	0.66	0.34–1.27
		C/C		0.61	0.30–1.27
	NC vs OC	G/C	0.51	1.21	0.65–2.24	0.32	0.71	0.36–1.39
		C/C		0.79	0.37–1.67
Variable	Groups	Dominant model			Allele model
		P-value	OR	95%CI	P-value	OR	95%CI
rs25487	Cases vs NC	0.00*	2.30	1.37–3.86	0.00*	2.05	1.39–3.04
	Cases vs OC	0.02*	1.88	1.10–3.22	0.00*	1.79	1.20–2.67
	NC vs OC	0.47	0.82	0.48–1.40	0.53	0.87	0.57–1.34
rs1042522	Cases vs NC	0.27	0.74	0.43–1.27	0.37	0.84	0.58–1.23
	Cases vs OC	0.37	0.78	0.45–1.34	0.17	0.77	0.52–1.12
	NC vs OC	0.87	1.05	0.59–1.86	0.64	0.91	0.62–1.34

OR Odd ratio, CI Confidence interval, NC Negative controls, OC Elderly patients above the age of 80

*indicated p-value< 0.05